Of the tracked stories, 1 of 2 also mention Americares, the most common co-covered peer. Across a 168-day span, the pace is roughly 0.1 stories per week. Source depth averages 3.5 original sources per story, versus 3.6 across the same-window beat baseline.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Gates Foundation
Of the tracked stories, 1 of 2 also mention Americares, the most common co-covered peer. Across a 168-day span, the pace is roughly 0.1 stories per week. Source depth averages 3.5 original sources per story, versus 3.6 across the same-window beat baseline. At 5.5, the average consequence score sits below the same-window beat average of 6. The clearest coverage concentration is funding: 1 of 2 stories, with the rest divided among 1 other category. This profile follows 2 Healthcare stories mentioning Gates Foundation across the period from March 26, 2026 to September 9, 2026.
Stories tracked
2
Per week
0.1
Sources per story
3.5
Computed from the 2 stories linked to this entity, with beat comparisons drawn from all 593 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Gates Foundation. Shared-story counts are live from our verified record — not editorial picks.
Americares announced a $50 million gift from an unnamed Connecticut family, the largest donation in its history, to expand medicine delivery to high-need areas.
Paysign 2026 Outlook
Paysign projects 30-35% revenue growth for the coming fiscal year.
Bezos parents commit $500 million to UNICEF
Jeff Bezos' parents pledged up to $500 million for UNICEF's Child Nutrition Fund, one of several large private responses to global aid funding gaps.
Recombinant Albumin Launch
Dyadic and ProLiant initiate commercial launch of recombinant albumin.
Dyadic Year-End Cash
Dyadic ends fiscal year with $8.6 million in cash and liquid assets.
Precigen Commercial Launch
Initial commercial shipments of Papzimius for adult RRP begin.
A $50 million anonymous gift to Americares will expand medicine delivery to high-need health centers as USAID cuts destabilize maternal, child, and HIV programs. The record donation shows how health philanthropies are stepping into funding gaps, though experts warn private wealth cannot replace billions lost.
The Q4 2025 earnings cycle marks a critical transition for mid-cap biotech and health-IT firms as they shift from R&D-heavy profiles to commercial-stage entities. Key players like Dyadic and Precigen are reporting initial product revenues and expanded distribution networks, while service providers like Paysign see massive growth in patient affordability programs.